IFN-β: A Contentious Player in Host–Pathogen Interaction in Tuberculosis
Open Access
- 16 December 2017
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (12) , 2725
Abstract
Tuberculosis (TB) is a major health threat to the human population worldwide. The etiology of the disease is Mycobacterium tuberculosis (Mtb), a highly successful intracellular pathogen. It has the ability to manipulate the host immune response and to make the intracellular environment suitable for its survival. Many studies have addressed the interactions between the bacteria and the host immune cells as involving many immune mediators and other cellular players. Interferon-β (IFN-β) signaling is crucial for inducing the host innate immune response and it is an important determinant in the fate of mycobacterial infection. The role of IFN-β in protection against viral infections is well established and has been studied for decades, but its role in mycobacterial infections remains much more complicated and debatable. The involvement of IFN-β in immune evasion mechanisms adopted by Mtb has been an important area of investigation in recent years. These advances have widened our understanding of the pro-bacterial role of IFN-β in host–pathogen interactions. This pro-bacterial activity of IFN-β appears to be correlated with its anti-inflammatory characteristics, primarily by antagonizing the production and function of interleukin 1β (IL-1β) and interleukin 18 (IL-18) through increased interleukin 10 (IL-10) production and by inhibiting the nucleotide-binding domain and leucine-rich repeat protein-3 (NLRP3) inflammasome. Furthermore, it also fails to provoke a proper T helper 1 (Th1) response and reduces the expression of major histocompatibility complex II (MHC-II) and interferon-γ receptors (IFNGRs). Here we will review some studies to provide a paradigm for the induction, regulation, and role of IFN-β in mycobacterial infection. Indeed, recent studies suggest that IFN-β plays a role in Mtb survival in host cells and its downregulation may be a useful therapeutic strategy to control Mtb infection.Keywords
Funding Information
- National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2015BAI09B01)
- National Key Research and Development Program of China (2017YFD0500901)
- National Natural Science Foundation of China (31572487)
- MoSTRCUK International Cooperation Project (2013DFG32500)
- High-end Foreign Experts Recruitment Program (GDW20151100036, GDW20161100071)
This publication has 151 references indexed in Scilit:
- Mycobacterium Tuberculosis Activates the DNA-Dependent Cytosolic Surveillance Pathway within MacrophagesCell Host & Microbe, 2012
- A functional genomic screen reveals novel host genes that mediate interferon-alpha’s effects against hepatitis C virusJournal of Hepatology, 2012
- Innate and Adaptive Interferons Suppress IL-1α and IL-1β Production by Distinct Pulmonary Myeloid Subsets during Mycobacterium tuberculosis InfectionImmunity, 2011
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and ImmunityImmunity, 2011
- Immune Signaling by RIG-I-like ReceptorsImmunity, 2011
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Distinct regulation of interleukin‐17 in human T helper lymphocytesArthritis & Rheumatism, 2007
- Host Innate Immune Response to Mycobacterium tuberculosisJournal of Clinical Immunology, 2007
- Pathogen Recognition and Innate ImmunityCell, 2006
- Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune ResponseImmunity, 2006